Ehsan Benrashid

Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice

The promise and challenge of therapeutic genome editing

The emerging role of lncRNAs in cancer

Long Noncoding RNAs in Cancer Pathways

In-frame Dystrophin Following Exon 51-Skipping Improves Muscle Pathology and Function in the Exon 52–Deficient mdx Mouse

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy

One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Mortality due to cancer treatment delay: systematic review and meta-analysis

Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread

Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer

Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival

Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy

Tunable protein synthesis by transcript isoforms in human cells

Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino

Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer